MX394131B - Partículas revestidas y sus usos. - Google Patents

Partículas revestidas y sus usos.

Info

Publication number
MX394131B
MX394131B MX2019013739A MX2019013739A MX394131B MX 394131 B MX394131 B MX 394131B MX 2019013739 A MX2019013739 A MX 2019013739A MX 2019013739 A MX2019013739 A MX 2019013739A MX 394131 B MX394131 B MX 394131B
Authority
MX
Mexico
Prior art keywords
coated particles
particles
coated
associating
binding
Prior art date
Application number
MX2019013739A
Other languages
English (en)
Other versions
MX2019013739A (es
Inventor
Andrew Glowacki
Latrisha Petersen
Meenakshi Patel
Robert Gambogi
Sherket Peterson
Original Assignee
Johnson & Johnson Consumer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Inc filed Critical Johnson & Johnson Consumer Inc
Publication of MX2019013739A publication Critical patent/MX2019013739A/es
Publication of MX394131B publication Critical patent/MX394131B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/85—Polyesters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A61Q11/02—Preparations for deodorising, bleaching or disinfecting dentures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5426—Polymers characterized by specific structures/properties characterized by the charge cationic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/61—Surface treated
    • A61K2800/62—Coated
    • A61K2800/622—Coated by organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/61—Surface treated
    • A61K2800/62—Coated
    • A61K2800/624—Coated by macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/654—The particulate/core comprising macromolecular material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Se proporcionan partículas revestidas y métodos de su uso para proporcionar beneficios para la salud; mas específicamente, la presente invención proporciona partículas revestidas de aminoácidos y/o polímeros, o partículas revestidas de otros materiales 5 para unirse a, o asociarse de cualquier otra manera con, superficies de la cavidad bucal.
MX2019013739A 2017-05-16 2018-05-16 Partículas revestidas y sus usos. MX394131B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762506783P 2017-05-16 2017-05-16
PCT/US2018/032928 WO2018213418A1 (en) 2017-05-16 2018-05-16 Coated particles and their uses

Publications (2)

Publication Number Publication Date
MX2019013739A MX2019013739A (es) 2020-01-20
MX394131B true MX394131B (es) 2025-03-04

Family

ID=62567795

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019013739A MX394131B (es) 2017-05-16 2018-05-16 Partículas revestidas y sus usos.

Country Status (10)

Country Link
US (2) US11291613B2 (es)
EP (1) EP3634372A1 (es)
JP (1) JP7234138B2 (es)
CN (1) CN110650721A (es)
AU (2) AU2018271102A1 (es)
BR (1) BR112019023287B1 (es)
CA (1) CA3060720A1 (es)
MX (1) MX394131B (es)
WO (1) WO2018213418A1 (es)
ZA (1) ZA201908358B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102509794B1 (ko) * 2020-01-09 2023-03-14 고려대학교 산학협력단 아미노산 기반의 항균 항생 계면활성 화합물 및 이를 포함하는 코어-쉘 구조의 나노 복합체
KR102304048B1 (ko) * 2021-01-12 2021-09-27 주식회사 엠알이노베이션 천연 식물 추출물을 포함하는 화장품용 plga 나노입자 및 이의 제조방법
CN115068369B (zh) * 2022-07-21 2022-11-15 北京吾星球科技有限公司 一种阳离子基质缓释体系及其制备方法及用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
US5874068A (en) 1997-12-08 1999-02-23 Warner-Lambert Company Stabilized antiplaque and antigingivitis oral compositions containing N.sup.α -alkyl-L-arginine alkyl ester salts
US10512597B2 (en) * 2007-09-06 2019-12-24 Colgate-Palmolive Company Controlled surface gelling of mucoadhesive polymers on oral mucosa
JP5841708B2 (ja) * 2008-07-01 2016-01-13 日東電工株式会社 表面被覆微粒子の医薬組成物
US9283184B2 (en) 2008-11-24 2016-03-15 Massachusetts Institute Of Technology Methods and compositions for localized agent delivery
JP2010275249A (ja) 2009-05-29 2010-12-09 Hosokawa Micron Corp 化粧料
US9591852B2 (en) 2009-11-23 2017-03-14 Mcneil-Ppc, Inc. Biofilm disruptive compositions
JP4856752B2 (ja) 2009-11-30 2012-01-18 ホソカワミクロン株式会社 薬物含有ナノ粒子の製造方法
WO2012013577A1 (en) * 2010-07-26 2012-02-02 Laboratorios Miret, S.A. Composition for coating medical devices containing lae and a polycationic amphoteric polymer
JP6017905B2 (ja) 2012-09-24 2016-11-02 花王株式会社 口腔用組成物
CA2902157A1 (en) 2013-02-25 2014-08-28 University Of Rochester Nanoparticles for controlled release of anti-biofilm agents
US9480703B2 (en) * 2013-10-29 2016-11-01 Shaker A. Mousa Method and composition of glycosaminoglycans in sickle cell and vascular disorders
US9975847B2 (en) * 2014-11-11 2018-05-22 Johnson & Johnson Consumer Inc. Amino acid derivatives and their uses
CN106890105B (zh) 2017-02-24 2019-06-04 四川大学 一种阳离子纳米颗粒及制备方法和应用

Also Published As

Publication number Publication date
WO2018213418A1 (en) 2018-11-22
CA3060720A1 (en) 2018-11-22
BR112019023287A8 (pt) 2022-07-26
BR112019023287A2 (pt) 2020-06-16
US11648186B2 (en) 2023-05-16
CN110650721A (zh) 2020-01-03
MX2019013739A (es) 2020-01-20
AU2024203897A1 (en) 2024-06-27
AU2018271102A1 (en) 2019-10-31
EP3634372A1 (en) 2020-04-15
RU2019141071A3 (es) 2021-10-04
US20190083367A1 (en) 2019-03-21
RU2019141071A (ru) 2021-06-16
US20220226205A1 (en) 2022-07-21
US11291613B2 (en) 2022-04-05
ZA201908358B (en) 2021-07-28
BR112019023287B1 (pt) 2023-02-14
JP2020520929A (ja) 2020-07-16
JP7234138B2 (ja) 2023-03-07

Similar Documents

Publication Publication Date Title
CY1123642T1 (el) Αντισωματα enanti-pd-1
ZA202107931B (en) Anti-tau antibodies and methods of use
CY1123274T1 (el) Αντισωματα εναντι-οχ40 και χρησεις αυτων
MX2024000300A (es) Anticuerpos antitau y metodos de uso.
CY1120646T1 (el) Προγονικα κυτταρα μεσοδερμικης προελευσης
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
JOP20190224A1 (ar) عمليات من أجل إنتاج الخلايا اللمفاوية المرتشحة للأورام واستخداماتها في العلاج المناعي
MX387587B (es) Formulaciones subcutáneas de anticuerpos anti-cd38 y sus usos.
EP3402493A4 (en) NEURAL ORGANOID COMPOSITION AND METHOD OF USE
MX2019006330A (es) Anticuerpos anti-tau y metodos de uso.
MX393455B (es) Anticuerpos anti-cd40 y sus usos.
SA518400237B1 (ar) SIRPa أجسم مضادة لـ جديدة وتطبيقاتها العلاجية
MA39248B1 (fr) Anticorps anti-jagged1 et procédés d'utilisation correspondants
CY1124727T1 (el) Πρωτεϊνες συντηξης tatk-cdkl5, συνθεσεις, φαρμακοτεχνικες μορφες και η χρηση αυτων
MX389001B (es) Moduladores de interacción de sestrina-gator2 y sus usos.
TWD165710S (zh) 電連接器
MX377774B (es) Formulaciones de proteinas.
EA201890439A1 (ru) ИММУНООНКОЛОГИЧЕСКАЯ МЕЗОДЕРМАЛЬНАЯ КЛЕТКА-ПРЕДШЕСТВЕННИК (ioMP-КЛЕТКА)
WO2016019036A3 (en) Recombinant collagen iv surrogates and uses thereof
MX394131B (es) Partículas revestidas y sus usos.
EP3687940A4 (en) SELF-ASSEMBLY PROCESSES TO FORM HEDGEHOG-SHAPED PARTICLES
TWD180565S (zh) 塗抹器
MX383460B (es) Derivados peptidicos novedosos y sus usos.
RU2014141377A (ru) Применение нанофосфолипидной композиции рифампицина совместно с протионамидом или его нанофосфолипидной формой в комбинированной противотуберкулезной терапии
UA104973U (uk) Біологічно активна добавка шумілова